about
sameAs
The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiencyHost-microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseMultiplex meta-analysis of RNA expression to identify genes with variants associated with immune dysfunctionJanus kinases in immune cell signalingAutosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairmentCombined immunodeficiency associated with DOCK8 mutationsGenomic views of STAT function in CD4+ T helper cell differentiationHigh levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous diseaseA homozygous CARD9 mutation in a family with susceptibility to fungal infectionsStable long-term cultures of self-renewing B cells and their applicationsThe Role of Staphylococcus aureus Virulence Factors in Skin Infection and Their Potential as Vaccine AntigensImpact of Bacterial and Human Genetic Variation on Staphylococcus aureus InfectionsType I/II cytokines, JAKs, and new strategies for treating autoimmune diseasesIL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicansEosinophilia Associated with Disorders of Immune Deficiency or Immune DysregulationSTAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertaintiesT-regulatory cells in primary immune deficienciesIntegrating non-coding RNAs in JAK-STAT regulatory networksHyper-IgE syndrome updateNewly recognized Mendelian disorders with rheumatic manifestationsEvaluation and differential diagnosis of marked, persistent eosinophiliaPrevention of infections during primary immunodeficiencyDiversity of IL-17-producing T lymphocytesAn update on the hyper-IgE syndromesMendelian genetics of human susceptibility to fungal infectionScreening approaches to generating STAT inhibitors: Allowing the hits to identify the targetsFlow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary ImmunodeficienciesPaving the way for predictive diagnostics and personalized treatment of invasive aspergillosisThe immunology of influenza virus-associated bacterial pneumoniaEndemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndromePrimary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitisEarly-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutationsHuman TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndromeClinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromesNext generation tools for the annotation of human SNPsImpaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndromeDifferentiation of effector CD4 T cell populations (*)Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.Patterns of Allergic Sensitization in High IgE Syndromes.
P2860
Q21202861-A4DFC63E-D7CB-4BDC-A77F-2EF0251DCB65Q22251082-37625BF4-0649-4FD8-B1DE-9DFB170FA590Q24289050-8C2F23CF-E4B2-49D7-9925-468AC476F98EQ24322021-14DD3876-F6C2-4C42-9B3A-FF721612517EQ24338530-C36BECAC-A848-4A33-ADDE-D19FD9C6799BQ24622094-22920822-688B-452E-9CB7-B50F8C79196AQ24628039-9843D3E7-A84B-4DDC-81FD-F51C6FA52A4AQ24633510-56C3A149-D5D4-40D4-BB4F-6E5CA2106831Q24658090-2047BE7F-13B3-4A0C-8FBE-A65F447C3DBFQ26766723-072B0E1F-4208-4BF0-B4E6-3EF72F5A3453Q26768436-BF94C05B-31BF-4CAB-956D-0CC2AF938AFFQ26772043-D1138007-0C37-4256-AB1B-75CA38CA95EEQ26775111-84D51C6C-FA7F-48E1-BA17-AEF3DA898A91Q26799351-0359B196-FC31-4749-AAA7-61F04AB5552CQ26799603-36D475A4-AD3D-4D55-892C-B1FB579E011DQ26829298-56093C78-B535-49FC-AD1B-403B65A3DAB0Q26862699-73C348D0-6FDA-475F-A7F7-766F13D9D70FQ26863279-8452582F-C11C-4300-809C-4743EC3770B4Q26994673-E2AB2734-AD7C-46CA-A77D-CB963DBF3524Q26996730-F822735B-6DBC-4948-94BE-62AB4540BEBFQ27001673-ED0D03B5-0B09-4982-AAAA-BB0D864FFF40Q27008430-4E066258-E461-424B-B0FC-28DAA3F8A8BEQ27010199-C92E5407-ACA7-4A4B-998C-73A04399FFA1Q27021598-96677D86-0047-44E6-8166-91BF244B6BA0Q27022250-6A58D770-2704-494C-AA6E-4429D0642E37Q27024482-2864E232-920A-4FE5-B9B5-08B6855475C2Q28076919-98FDF85E-470A-4FCD-B73E-8D9303935C1AQ28081259-2FAB9AEB-6D47-41B5-92E9-D930396F7AFEQ28084679-CEF0619C-6E5B-4706-B7A5-93BDDCBE013DQ28084749-294143CB-E12D-4C80-A305-979655CD0BE6Q28086897-9A365CE3-7DC4-422F-9D6E-A17B3A777474Q28250725-7C0F7DB4-C22C-443B-99BF-F44C25AEE85BQ28266613-748A5D33-CD6E-4C78-8C88-063DC44CDC94Q28308116-22D955A9-1024-4720-86FB-7CC71FAFD941Q28755491-989F868D-87E2-489B-9640-8C23CE807A9CQ29614595-C9D02096-0C9F-4314-A296-2CAAA5B83E42Q29614838-3B555E50-87F7-4BD3-9E76-D98650FE2597Q30239977-194D3563-23E9-4054-A61C-A911F434960BQ30274910-4545B452-EA6B-4A09-AA9C-C6D8B910A9D9Q30278478-2DACD337-D11B-4FC9-B53C-47649BC2BECD
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
STAT3 mutations in the hyper-IgE syndrome
@ast
STAT3 mutations in the hyper-IgE syndrome
@en
STAT3 mutations in the hyper-IgE syndrome
@nl
type
label
STAT3 mutations in the hyper-IgE syndrome
@ast
STAT3 mutations in the hyper-IgE syndrome
@en
STAT3 mutations in the hyper-IgE syndrome
@nl
altLabel
STAT3Mutations in the Hyper-IgE Syndrome
@en
STAT3Mutations in the Hyper-IgE Syndrome
@nl
prefLabel
STAT3 mutations in the hyper-IgE syndrome
@ast
STAT3 mutations in the hyper-IgE syndrome
@en
STAT3 mutations in the hyper-IgE syndrome
@nl
P2093
P50
P356
P1476
STAT3 mutations in the hyper-IgE syndrome
@en
STAT3Mutations in the Hyper-IgE Syndrome
@en
P2093
Adeline R Whitney
Adeline R. Whitney
Alejandro A Schäffer
Alejandro A. Schäffer
Alexandra F Freeman
Alexandra F. Freeman
Amy P. Hsu
Andrew Demidowich
Bodo Grimbacher
P304
P356
10.1056/NEJMOA073687
P407
P577
2007-10-18T00:00:00Z